NCCN Guidelines® Insights - Non-Hodgkin’s Lymphoma, 1.2013
These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Non-Hodgkin’s Lymphoma (NHL) and provide a discussion of the clinical evidence that support the updates. The updates discussed in this article feature recommendations for additional treatment options in patients with chronic lymphocytic leukemia and guidance surrounding the management of hepatitis virus reactivation/infections in high-risk patients with NHL undergoing antitumor therapy.
This activity has been designated to meet the educational needs of physicians, nurses, and pharmacists involved in the management of patients with cancer.
Upon completion of this activity, participants will be able to:
- Integrate into professional practice the updates to NCCN Guidelines for NHL
- Describe the rationale behind the decision-making process for developing the NCCN Guidelines for NHL
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician